EMEA-001198-PIP03-17-M04
Key facts
| Invented name |
Akynzeo
|
| Active substance |
|
| Therapeutic area |
Other
|
| Decision number |
P/0272/2020
|
| PIP number |
EMEA-001198-PIP03-17-M04
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Prevention of chemotherapy-induced nausea and vomiting
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Helsinn Birex Pharmaceuticals Limited
E-mail: paediatrics-netu@helsinn.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|